Tasks required to nurture domestic pharmaceutical firms' competitiveness

Published: 2003-10-17 07:00:00

Updated: 2003-10-17 07:00:00

In light of the increasingly competitive pharmaceutical environment in the global market, domestic drug makers should retain better profitability in a bide to ensure substantial R&D spending, strengthened export drive and streamlined R&D activities to expand Korea's infrastructure for the develop...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK